GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDenta Corp (OTCPK:IDTA) » Definitions » Common Stock

IDTA (IDenta) Common Stock : $0.00 Mil (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is IDenta Common Stock?

IDenta's quarterly common stock stayed the same from Mar. 2024 ($0.00 Mil) to Jun. 2024 ($0.00 Mil) and stayed the same from Jun. 2024 ($0.00 Mil) to Sep. 2024 ($0.00 Mil).

IDenta's annual common stock stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) and stayed the same from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).


IDenta Common Stock Historical Data

The historical data trend for IDenta's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDenta Common Stock Chart

IDenta Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial - - - - -

IDenta Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

IDenta Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


IDenta Business Description

Traded in Other Exchanges
N/A
Address
Bethlehem Road 120, Jerusalem, ISR, 9342001
IDenta Corp is a detection and forensic science company. The firm, through its subsidiary, is engaged in the business of developing products to test for the presence of illegal drugs and explosives for law enforcement agencies, the military, government agencies, and other organizations. Its product portfolio includes Drug testing kits, Explosive testing kits, Precursors of Drugs Test kits, portable sniffers, Bullet-hole testing kits, and others. The Company currently sells its products to law enforcement organizations in the following countries Indonesia, Argentina, Poland, France, USA, Spain, India, the United Kingdom, Ghana, Nigeria, Australia, Russia, Israel, Canada, Germany, Italy, and Portugal. The Company also sells to retail markets in the United States, Italy, and South Africa.